Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 28, 2017; 23(32): 5969-5976
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5969
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5969
Patient number | 1 | 2 | 3 | 4 | 5 | 6 |
Age/gender | 47/M | 40/M | 40/M | 48/M | 48/M | 49/M |
Pre-treatment serum HCV viral load (IU/mL) | 3.2E+6 | 8.6E+5 | 1.4E+7 | 5.14E+5 | 2.95E+7 | 8.08E+5 |
HCV genotype | 1b | 1b | 3a | 1b | 6a | 1b |
Anti-HCV | Negative | Positive | Positive | Positive | Negative | Positive |
Cirrhosis | No | No | No | No | No | No |
Number of kidney transplantations | Two | One | One | One | One | One |
Prior antiviral therapy | No | No | No | No | No | No |
Baseline serum Cr (μmol/L) (n = 53-115) | 75.5 | 84.2 | 146.6 | 175.6 | 128 | 89.3 |
Baseline eGFR (mL/min) | 63.63 | 80.04 | 42.86 | 30.94 | 48.29 | 61.85 |
Baseline Hgb (g/dL) | 113 | 136 | 121 | 111 | 167 | 137 |
Baseline ALT (IU/L) | 68 | 67 | 26 | 13 | 26 | 44 |
Baseline AST (IU/L) | 161 | 143 | 42 | 27 | 42 | 54 |
Baseline γ-GT (IU/L) | 162 | 621 | 55 | 25 | 60 | 54 |
Baseline TB (μmol/L) | 30 | 29.2 | 9.6 | 8 | 18.7 | 12.5 |
Baseline (Hb g/L) | 113 | 136 | 121 | 94 | 167 | 137 |
Complication | Hypertension | Hypertension | Hypertension | Hypertension | Hypertension/Diabetes | Hypertension |
Antiviral regimen | Sofosbuvir 400 mg daily + daclatasvir 6 0mg daily | Sofosbuvir 400 mg daily + daclatasvir 60 mg daily | Sofosbuvir 400 mg daily + daclatasvir 60 mg daily + ribavirin 0.6 g daily | Sofosbuvir 400 mg daily + daclatasvir 60 mg daily | Sofosbuvir 400 mg daily + daclatasvir 60 mg daily | Sofosbuvir 400 mg daily + daclatasvir 60 mg daily |
Treatment duration (wk) | 12 | 12 | 12 | 12 | 12 | 12 |
Baseline immunosuppressive regimen | Mycophenolatemofetil 500 mg bid | Mycophenolate mofetil 540 mg bid | Mycophenolate mofetil 540 mg bid | Mycophenolate mofetil 750 mg bid | Cyclosporin A 75 mg bid | Mycophenolate mofetil 720 mg bid |
Tacrolimus (FK506) 0.5 mg bid | Tacrolimus (FK506)1.5 mg bid | Tacrolimus (FK506)2 mg bid | Tacrolimus 2 mg bid | Mycophenolate mofetil 540 mg bid | Tacrolimus (FK506) 0.5 mg bid | |
Methylprednisolone 4 mg qd | Prednisone 5 mg qd | Prednisone 5mg qd | Prednisone 5 mg qd | Prednisone 5 mg qd | Methylprednisolone 4 mg qd | |
Baseline anti-hypertension regimen | Metoprolol 12.5 mg qd | Benazepril 10 mg | Benazepril 10 mg bid | Valsartan 80 mg bid | Irbesartan 150 mg bid | None |
qd | ||||||
Valsartan 80 mg qd | ||||||
Other regimens | Benzbromarone tablets 12.5 mg bid | Recombinant human erythropoietin injection 10000 U, IH, biw |
- Citation: Xue Y, Zhang LX, Wang L, Li T, Qu YD, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol 2017; 23(32): 5969-5976
- URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5969.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i32.5969